Showing results (171-180 of 263) with videos related to

Sort By:
Pageof 27
Communicable Diseases Intelligence Quarterly Report|August 30, 2007
Creutzfeldt-Jakob disease: Australian surveillance update to March 2007Genevieve M Klug, Alison Boyd, Victoria Lewis, et al.
Neurobiology of Disease|October 26, 2005
Extended period of asymptomatic prion disease after low dose inoculation: assessment of detection methods and implications for infection controlSteven J Collins, Victoria Lewis, Marcus W Brazier, et al.
Journal of Alzheimer'S Disease : JAD|March 1, 2019
Comparative Utility of Manual versus Automated Segmentation of Hippocampus and Entorhinal Cortex Volumes in a Memory Clinic SampleYi Leng Fung, Kelly E T Ng, Simon J Vogrin, et al.
Free Radical Biology & Medicine|March 3, 2009
Formation of dopamine-mediated alpha-synuclein-soluble oligomers requires methionine oxidationSu Ling Leong, Chi L L Pham, Denise Galatis, et al.
Neurotoxicity Research|September 18, 2009
A serial analysis of gene expression profile of the Alzheimer's disease Tg2576 mouse modelAmee J George, Lavinia Gordon, Tim Beissbarth, et al.
Communicable Diseases Intelligence Quarterly Report|October 31, 2013
Surveillance for Creutzfeldt-Jakob disease in Australia: update to December 2012Genevieve M Klug, Alison Boyd, Teresa Zhao, et al.
Communicable Diseases Intelligence Quarterly Report|March 10, 2017
Creutzfeldt-Jakob disease surveillance in Australia: update to December 2015Genevieve M Klug, Alison Boyd, Shannon Sarros, et al.
Journal of Neuropathology and Experimental Neurology|November 18, 2009
Increased proportions of C1 truncated prion protein protect against cellular M1000 prion infectionVictoria Lewis, Andrew F Hill, Cathryn L Haigh, et al.
Neuroreport|May 9, 2002
Alternative transcripts of presenilin-1 associated with frontotemporal dementiaGeneviève Evin, Margaret J Smith, Angela Tziotis, et al.
Pageof 27